Premium
Immobilization technique for enhanced production of the immunosuppressant mycophenolic acid by ultraviolet and gamma‐irradiated P enicillium roqueforti
Author(s) -
Ismaiel A.A.,
Ahmed A.S.,
ElSayed E.R.
Publication year - 2015
Publication title -
journal of applied microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 1364-5072
DOI - 10.1111/jam.12828
Subject(s) - penicillium roqueforti , mycelium , spore , fermentation , penicillium , chemistry , food science , calcium alginate , irradiation , bioreactor , chromatography , erlenmeyer flask , microbiology and biotechnology , nuclear chemistry , biology , botany , organic chemistry , physics , nuclear physics , calcium
Aims Different entrapment matrices were screened to immobilize two strains of Penicillium roqueforti ( AG 101 and LG 109) for more effective production of mycophenolic acid ( MPA ). Further improvement in the MPA productivity from immobilization of spores and mycelia was adopted by UV and gamma irradiation. Methods and Results Penicillium roqueforti strains were immobilized in different entrapping carriers and used for MPA production in shake flask cultures. Maximum MPA production was achieved on using an alginate concentration of 3·0% (w/v) and a mycelial fresh weight of 10% (w/v). MPA produced by alginate‐immobilized spores and mycelia was almost double in comparison to the free system. The MPA ‐producing ability of immobilized AG 101 and LG 109 strain was significantly enhanced by mutagenesis through irradiation by UV (254 nm) for 120 and 90 min, respectively and gamma rays at 0·75 KGy. The feasibility of MPA production in a semi‐continuous form by immobilized cells as affected by irradiation was adopted. Conclusions MPA production by immobilized spores and mycelia was more intensified by UV and gamma irradiation. Moreover, the immobilized cell culture was superior to free‐cell culture. Significance and Impact of the Study These findings indicate the future possibility to reduce the cost of producing fermentation‐based drugs.